Safety and Efficacy of Newer Oral Anticoagulants Versus Vitamin K Antagonists in the Management of Cerebral Venous Thrombosis: A Single-Center Ambispective Study from South India by Rithvik Ramesh, Lakshmi Narasimhan Ranganathan, Sriram Raguraman, Kamlesh Jayakumar, Braveen Rajamanoharan, Varun Kishore Loganathan, Philo Hazeena, Sundar Shanmugam, Deepa Avadhani, Karthik Sankar

Subjects: Get full text

Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phas... by Rabih R. Azar, Hany I. Ragy, Omer Kozan, Maurice El Khuri, Nooshin Bazergani, Sabrina Marler, Christine Teutsch, Mohamed Ibrahim, Gregory Y.H. Lip, Menno V. Huisman

Subjects: Get full text

Efficacy and safety outcomes in novel oral anticoagulants versus vitamin-K antagonist on post-TAVI patients: a meta-analysis by Hongbin Liang, Qiyu He, Qiuxia Zhang, Xuewei Liu, Kai Cui, Guojun Chen, Jiancheng Xiu

Subjects: “…NOACs…”
Get full text

Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings by Maja Muric, Marina Nikolic, Andreja Todorovic, Vladimir Jakovljevic, Ksenija Vucicevic

Subjects: “…NOACs…”
Get full text

The safety and efficacy of NOACs versus LMWH for thromboprophylaxis after THA or TKA: A systemic review and meta-analysis by Kai Ding, Wei Yan, Yifan Zhang, Jiaxing Li, Congxin Li, Chunhui Liang

Subjects: Get full text

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis by Zei Li, Yingming Zheng, Dandan Li, Xiaozhen Wang, Sheng Cheng, Xiao Luo, Aiping Wen

Subjects: Get full text

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies by Reddy VY, Zhong Y, McGovern AM, Amorosi SL, Gavaghan MB, Hertz DS, Low K, Freeman S, Holmes DR Jr

Subjects: Get full text

Real-world national trends and influencing factors preference of non-vitamin K antagonist oral anticoagulants in China by Shaojing Zhu, Mengjie Li, Lujun Wang, Lu Hou, Dandan Li, Jiuhong Liu, Yanxia Lu

Subjects: “…NOACs…”
Get full text

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis by Adel Khalifa Sultan Hamad

Subjects: “…anticoagulants; covid-19; noacs; sarscov-2; thrombosis…”
Get full text

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants by Raphael Chinedu Anakwue

Subjects: Get full text

Prolonged Secondary Stroke Prevention with Edoxaban: A Long-Term Follow-Up of the SATES Study by Irene Scala, Simone Bellavia, Pier Andrea Rizzo, Jacopo Di Giovanni, Mauro Monforte, Roberta Morosetti, Giacomo Della Marca, Fabio Pilato, Aldobrando Broccolini, Paolo Profice, Giovanni Frisullo

Subjects: “…NOACs…”
Get full text

Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable? by Krishnan Shyamkumar, Jack Hirsh, Vinai C. Bhagirath, Jeffrey S. Ginsberg, John W. Eikelboom, Noel C. Chan

Subjects: Get full text

World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update by Ben Freedman, Gerhard Hindricks, Amitava Banerjee, Adrian Baranchuk, Chi Keong Ching, Xin Du, Donna Fitzsimons, Jeff S. Healey, Takanori Ikeda, Trudie C. A. Lobban, Amam Mbakwem, Calambur Narasimhan, Lis Neubeck, Peter Noseworthy, Daniel M. Philbin, Fausto J. Pinto, Joselyn Rwebembera, Renate B. Schnabel, Jesper Hastrup Svendsen, Luis Aguinaga, Elena Arbelo, Michael Böhm, Hasan Ali Farhan, F. D. Richard Hobbs, Antoni Martínez-Rubio, Claudio Militello, Nitish Naik, Jean Jacques Noubiap, Pablo Perel, Daniel José Piñero, Antonio Luiz Ribeiro, Janina Stepinska

Subjects: Get full text

The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation: Case reports by Tomić Milan

Subjects: “…novel oral anticoagulants (noacs)…”
Get full text

Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies by Zhi-Yan Liu, Han-Xu Zhang, Ling-Yue Ma, Guang-Yan Mu, Qiu-Fen Xie, Shuang Zhou, Zi-Ning Wang, Zhe Wang, Kun Hu, Qian Xiang, Yi-Min Cui

Subjects: “…NOACs…”
Get full text

Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis by Huda Moutaz Asmael Al-Azzawi, Syed Ameer Hamza, Rita Paolini, Fizza Arshad, Romeo Patini, Lorraine O’Reilly, Lorraine O’Reilly, Michael McCullough, Antonio Celentano

Subjects: Get full text

Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation by Giuseppe Patti, Ludmilla Mantione, Edoardo Bressi, Antonio Bisignani

Subjects: Get full text

PE-035 Custo-efetividade dos anticoagulantes na fibrilação atrial não valvar by Raphael Fernando Boiati, Iasmin Silva Vasconcelos, Victor Luiz Vieira Gomes Pinto, Luiz Claudio Behrmann Martins, Carla Rudge Lima Netto, Vitor Hugo Fernandes Martins, Fabricia de Lima Alves, Myrian Kazumi Sano

Subjects: “…Fibrilação Atrial; NOACs; Anticoagulantes Orais; Varfarina; Ensaios Clínicos.…”
Get full text

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants by Jo-Nan Liao, Jo-Nan Liao, Yi-Hsin Chan, Yi-Hsin Chan, Yi-Hsin Chan, Ling Kuo, Ling Kuo, Chuan-Tsai Tsai, Chuan-Tsai Tsai, Su-Shen Lim, Su-Shen Lim, Tze-Fan Chao, Tze-Fan Chao

Subjects: Get full text

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation by Jose Miguel Calderon, Fernando Martinez, Fernando Martinez, Javier Diaz, Antonio Fernandez, Inmaculada Sauri, Ruth Uso, Jose Luis Trillo, Sara Vela, Carlos Bea, Josep Redon, Josep Redon, Josep Redon, Maria Jose Forner, Maria Jose Forner

Subjects: Get full text